Mambrini, Andrea <br/><br/>
Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.  [electronic resource] 

 -  Anticancer research   
 - 3009-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biliary Tract Neoplasms--drug therapy<br/>Capecitabine<br/>Cholangiocarcinoma--drug therapy<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Hepatic Artery<br/>Humans<br/>Infusions, Intra-Arterial<br/>Male<br/>Middle Aged